Clinical trial
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic…
NCT00475605 · LEO Pharma, Industry · Terminated
Key facts
| NCT number | NCT00475605 |
|---|---|
| Title | A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis |
| Official title | APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis |
| Acronym | APPLES |
| Lead sponsor | LEO Pharma, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Atopic Dermatitis |
| Enrollment | 8,071 |
| Start date | May 25, 2005 |
| Primary completion | Jan 31, 2019 |
| Completion | Jan 31, 2019 |
| First posted | May 21, 2007 |
| Last update posted | Dec 18, 2019 |
| Countries | Austria, Canada, France, Germany, Ireland, Netherlands, Poland, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: